Ozempic maker Novo Nordisk boots CEO over stock-price fall

marketwatch.com/story/ozempic-maker-novo-nordisk-boots-ceo-over-stock-price-fall-fc4ab28f

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.

This story appeared on marketwatch.com, 2025-05-16 11:50:00.
The Entire Business World on a Single Page. Free to Use →